关键词: facial hyperpigmentation latanoprost

Mesh : Administration, Cutaneous Administration, Ophthalmic Aged Antihypertensive Agents / administration & dosage adverse effects Biopsy Brimonidine Tartrate / administration & dosage Dermatologic Agents / administration & dosage Drug Substitution Face Female Glaucoma / drug therapy Humans Hyperpigmentation / chemically induced diagnosis pathology therapy Lasers, Solid-State / therapeutic use Latanoprost / administration & dosage adverse effects Low-Level Light Therapy / instrumentation methods Ophthalmic Solutions / administration & dosage adverse effects Skin / drug effects pathology Skin Pigmentation / drug effects Treatment Outcome

来  源:   DOI:10.1111/jocd.12920   PDF(Sci-hub)

Abstract:
BACKGROUND: Latanoprost is a prostaglandin F2α analogue, which has been used as a first-line drug for open-angle glaucoma. Common side effects of latanoprost include hyperpigmentation. While it usually occurs on irides or periocular skin, diffuse facial hyperpigmentation is rarely reported.
METHODS: A 71-year-old woman was presented with diffuse gray-brown colored maculopatches on her face. The symptom appeared 1 week after she started to use latanoprost eye drops for glaucoma. Biopsy specimen revealed vacuolar degeneration of dermo-epidermal junction and pigment incontinence in dermis.
OBJECTIVE: The aim of this paper is to introduce a rare adverse effect of latanoprost and effective way of treatment.
METHODS: We stopped her from using latanoprost. She was also treated with 532-nm potassium titanyl phosphate laser and low-fluence 1064-nm Q-switched Nd:YAG laser, while using topical agents.
RESULTS: After 10 weeks, we observed hyperpigmentation of her face was effectively and safely treated. The patient was satisfied with the result.
CONCLUSIONS: Diffuse facial pigmentation could be one of the latanoprost-induced adverse effects and the laser treatments with topical agents we used can make it improve faster.
摘要:
暂无翻译
公众号